Correlation Between Zealand Pharma and Sprint

By analyzing existing cross correlation between Zealand Pharma AS and Sprint you can compare the effects of market volatilities on Zealand Pharma and Sprint and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zealand Pharma with a short position of Sprint. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zealand Pharma and Sprint.

Specify exactly 2 symbols:

Can any of the company-specific risk be diversified away by investing in both Zealand Pharma and Sprint at the same time? Although using correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combing Zealand Pharma and Sprint into the same portfolio which is an essential part of fundamental portfolio management process.

Diversification Opportunities for Zealand Pharma and Sprint

0.2
Correlation
<div class='circular--portrait-small' style='font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:1.1em;padding-top: 10px;;'>ZP</div>
<div class='circular--portrait-small' style='font-weight: 700;background:#800000;color: #F8F8FF;font-size:1.7em;padding-top:4px;;'>S</div>

Modest diversification

The 3 months correlation between Zealand and Sprint is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Zealand Pharma AS and Sprint Corp. in the same portfolio assuming nothing else is changed. The correlation between historical prices or returns on Sprint and Zealand Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zealand Pharma AS are associated (or correlated) with Sprint. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sprint has no effect on the direction of Zealand Pharma i.e. Zealand Pharma and Sprint go up and down completely randomly.

Pair Corralation between Zealand Pharma and Sprint

Assuming 30 trading days horizon, Zealand Pharma AS is expected to generate 1.52 times more return on investment than Sprint. However, Zealand Pharma is 1.52 times more volatile than Sprint. It trades about 0.04 of its potential returns per unit of risk. Sprint is currently generating about 0.0 per unit of risk. If you would invest  24,920  in Zealand Pharma AS on May 5, 2020 and sell it today you would earn a total of  980.00  from holding Zealand Pharma AS or generate 3.93% return on investment over 30 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy87.1%
ValuesDaily Returns

Zealand Pharma AS  vs.  Sprint Corp.

 Performance (%) 
      Timeline 
Zealand Pharma AS 
22

Zealand Pharma Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in Zealand Pharma AS are ranked lower than 2 (%) of all global equities and portfolios over the last 30 days. Allthough quite conflicting forward indicators, Zealand Pharma disclosed solid returns over the last few months and may actually be approaching a breakup point.
Sprint 
00

Sprint Risk-Adjusted Performance

Over the last 30 days Sprint has generated negative risk-adjusted returns adding no value to investors with long positions. In defiance of relatively invariable forward-looking signals, Sprint is not utilizing all of its potentials. The prevalent stock price agitation, may contribute to short term losses for the management.

Zealand Pharma and Sprint Volatility Contrast

 Predicted Return Density 
      Returns 
Check out your portfolio center. Please also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..


 
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page